King & Spalding advised Evolent Health, Inc. on the offering, and Davis Polk & Wardwell advised the representative of the initial purchasers. Evolent Health, Inc. (NYSE:...
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here